Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|December 24, 2013
4-Hydroxy hexenal derived from dietary n-3 polyunsaturated fatty acids induces anti-oxidative enzyme heme oxygenase-1 in multiple organsFumiyuki Nakagawa, Katsutaro Morino, Satoshi Ugi, et al.Obesity (Silver Spring, Md.)|December 19, 2009
Relation of the expression of transcriptional factor TFAP2B to that of adipokines in subcutaneous and omental adipose tissuesSatoshi Ugi, Yoshihiko Nishio, Hiroshi Yamamoto, et al.Journal of Biochemistry|July 17, 2009
Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression and consequent hypertriglyceridaemiaSatoshi Ugi, Kun Shi, Yoshihiko Nishio, et al.Diabetes|December 12, 2025
miR-494 Deletion Improves Glucose Metabolism Independently of Obesity in MiceLucia Sugawara, Katsutaro Morino, Hirotaka Iwasaki, et al.Journal of Diabetes Investigation|December 12, 2018
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: A randomized clinical trialHideka Inoue, Katsutaro Morino, Satoshi Ugi, et al.Plos One|June 28, 2014
Predictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetesShinji Kume, Shin-ichi Araki, Nobukazu Ono, et al.Plos One|June 30, 2017
Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trialKeiko Kondo, Katsutaro Morino, Yoshihiko Nishio, et al.BMJ Open Diabetes Research & Care|May 23, 2019
Total energy expenditure is comparable between patients with and without diabetes mellitus: Clinical Evaluation of Energy Requirements in Patients with Diabetes Mellitus (CLEVER-DM) StudyKatsutaro Morino, Keiko Kondo, Shigeho Tanaka, et al.Diabetes Research and Clinical Practice|February 19, 2022
Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trialKayo Horibe, Katsutaro Morino, Itsuko Miyazawa, et al.Plos One|August 13, 2013
4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activationAtsushi Ishikado, Katsutaro Morino, Yoshihiko Nishio, et al.Pageof 10